Lu Z, Stencel O, Liu W, Vasileiou E, Xu H, Pandey P
EMBO Mol Med. 2025; .
PMID: 40082582
DOI: 10.1038/s44321-025-00208-4.
Akula S, Alvarado-Vazquez A, Haide Mendez Enriquez E, Bal G, Franke K, Wernersson S
Int J Mol Sci. 2024; 25(23).
PMID: 39684762
PMC: 11642334.
DOI: 10.3390/ijms252313050.
Ma X, Lin L, Zhao Q, Iqbal M
Brief Bioinform. 2024; 26(1).
PMID: 39581871
PMC: 11586128.
DOI: 10.1093/bib/bbae615.
Pruitt L, Abbott R
Front Immunol. 2024; 15:1478506.
PMID: 39559353
PMC: 11570280.
DOI: 10.3389/fimmu.2024.1478506.
Nie J, Ng A, Nutt S
Nat Immunol. 2024; 25(12):2173-2175.
PMID: 39487350
DOI: 10.1038/s41590-024-02019-0.
YY1 knockout in pro-B cells impairs lineage commitment, enabling unusual hematopoietic lineage plasticity.
Banerjee S, Sanyal S, Hodawadekar S, Naiyer S, Bano N, Banerjee A
Genes Dev. 2024; 38(17-20):887-914.
PMID: 39362773
PMC: 11535188.
DOI: 10.1101/gad.351734.124.
Rack1 regulates B-cell development and function by binding to and stabilizing the transcription factor Pax5.
Zhang X, Ma C, Lu Y, Wang J, Yun H, Jiang H
Cell Mol Immunol. 2024; 21(11):1282-1295.
PMID: 39256480
PMC: 11528059.
DOI: 10.1038/s41423-024-01213-2.
Transcriptional function of E2A, Ebf1, Pax5, Ikaros and Aiolos analyzed by in vivo acute protein degradation in early B cell development.
Fedl A, Tagoh H, Gruenbacher S, Sun Q, Schenk R, Froussios K
Nat Immunol. 2024; 25(9):1663-1677.
PMID: 39179932
DOI: 10.1038/s41590-024-01933-7.
Unraveling Copy Number Alterations in Pediatric B-Cell Acute Lymphoblastic Leukemia: Correlation with Induction Phase Remission Using MLPA.
Aisyi M, Andriastuti M, Kosasih A, Utomo A, Saputra F, Tjitra Sari T
Asian Pac J Cancer Prev. 2024; 25(7):2421-2426.
PMID: 39068576
PMC: 11480619.
DOI: 10.31557/APJCP.2024.25.7.2421.
Early B-Cell Factor 1: An Archetype for a Lineage-Restricted Transcription Factor Linking Development to Disease.
Sigvardsson M
Adv Exp Med Biol. 2024; 1459:143-156.
PMID: 39017843
DOI: 10.1007/978-3-031-62731-6_7.
Plasma cell differentiation is regulated by the expression of histone variant H3.3.
Saito Y, Harada A, Ushijima M, Tanaka K, Higuchi R, Baba A
Nat Commun. 2024; 15(1):5004.
PMID: 38902223
PMC: 11190180.
DOI: 10.1038/s41467-024-49375-x.
Vpr driving DNA methylation variation of CD4 + T cells in HIV-1 infection.
Wang P, Meng Z, Deng K, Gao Z, Cai J
Virol J. 2024; 21(1):97.
PMID: 38671522
PMC: 11046818.
DOI: 10.1186/s12985-024-02363-5.
The Expression Levels of CD20 as a Prognostic Value in Feline B-Cell Nasal Lymphoma: A Pilot Study.
Chaipoca K, Sirinarumitr T, Srisampan S, Wongsali C, Kovitvadhi A, Jaroensong T
Animals (Basel). 2024; 14(7).
PMID: 38612282
PMC: 11010812.
DOI: 10.3390/ani14071043.
Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia.
Huang X, Li Y, Zhang J, Yan L, Zhao H, Ding L
Cancer Cell. 2024; 42(4):552-567.e6.
PMID: 38593781
PMC: 11008188.
DOI: 10.1016/j.ccell.2024.03.003.
Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers.
Fan J, Thanedar S, Ovechko V, Jana B
Case Rep Oncol. 2024; 17(1):517-523.
PMID: 38549625
PMC: 10978043.
DOI: 10.1159/000536571.
ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia.
Behrens K, Brajanovski N, Xu Z, Viney E, DiRago L, Hediyeh-Zadeh S
Sci Adv. 2024; 10(10):eadj8803.
PMID: 38457494
PMC: 10923517.
DOI: 10.1126/sciadv.adj8803.
Transcriptomic Analysis Reveals Sixteen Potential Genes Associated with the Successful Differentiation of Antibody-Secreting Cells through the Utilization of Unfolded Protein Response Mechanisms in Robust Responders to the Influenza Vaccine.
Tawfik A, Kawaguchi T, Takahashi M, Setoh K, Yamaguchi I, Tabara Y
Vaccines (Basel). 2024; 12(2).
PMID: 38400120
PMC: 10892001.
DOI: 10.3390/vaccines12020136.
Concepts in B cell acute lymphoblastic leukemia pathogenesis.
Garcia C, Miller-Awe M, Witkowski M
J Leukoc Biol. 2024; 116(1):18-32.
PMID: 38243586
PMC: 11869204.
DOI: 10.1093/jleuko/qiae015.
From Genotype to Phenotype: How Enhancers Control Gene Expression and Cell Identity in Hematopoiesis.
Mulet-Lazaro R, Delwel R
Hemasphere. 2023; 7(11):e969.
PMID: 37953829
PMC: 10635615.
DOI: 10.1097/HS9.0000000000000969.
Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL.
Fregona V, Bayet M, Bouttier M, Largeaud L, Hamelle C, Jamrog L
J Exp Med. 2023; 221(1).
PMID: 37930337
PMC: 10626194.
DOI: 10.1084/jem.20230279.